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AbstrACt
Objective To examine geographic variation in use of 
surgery for female stress urinary incontinence (SUI), mainly 
midurethral mesh tape insertions, in the English National 
Health Service (NHS).
Design National cohort study.
setting NHS hospitals.
Participants 27 997 women aged 20 years or older who 
had a first SUI surgery in an English NHS Hospital between 
April 2013 and March 2016 and a diagnosis of SUI at the 
same time as the procedure.
Methods Multilevel Poisson regression was used to adjust 
for geographic differences in age, ethnicity, prevalence of 
long-term illness and socioeconomic deprivation.
Primary outcome measure Rate of surgery for SUI per 
100 000 women/year at two geographic levels: Clinical 
Commissioning Group (CCG; n=209) and Sustainability and 
Transformation Partnership (STP; n=44).
results The rate of surgery for SUI was 40 procedures 
per 100 000 women/year. Risk-adjusted rates ranged from 
20 to 106 procedures per 100 000 women/year across 
CCGs and 24 to 69 procedures per 100 000 women/year 
across the STP areas. These regional differences were 
only partially explained by demographic characteristics 
as adjustment reduced variance of surgery rates by 16% 
among the CCGs and 35% among the STPs.
Conclusions Substantial geographic variation exists 
in the use of surgery for female SUI in the English NHS, 
suggesting that women in some areas are more likely to 
be treated compared with women with the same condition 
in other areas. The variation reflects differences in how 
national guidelines are being interpreted in the context of 
the ongoing debate about the safety of SUI surgery.
IntrODuCtIOn
Urinary incontinence (UI) is estimated to 
affect 30% to 40% of women in the UK.1 2 The 
condition has a significant impact on quality 
of life,3 affecting physical and social activi-
ties, confidence and self-perception.4 Stress 
urinary incontinence (SUI), the involuntary 
loss of urine with increases in abdominal pres-
sure such as when exercising or coughing, is 
the most commonly diagnosed type of incon-
tinence in women, accounting for approx-
imately 50% of all UI diagnoses.5 Urgency 
urinary incontinence (UUI) is characterised 
by a sudden and compelling desire to pass 
urine that is difficult to defer. Many women 
experience coexisting stress and UUI symp-
toms, a subtype often called mixed urinary 
incontinence. UI is managed at the primary 
care level initially.6 Lifestyle changes may be 
recommended in primary care where women 
with UI also smoke cigarettes, report exces-
sive fluid or caffeine consumption or are 
overweight or obese.7 Surgical treatments are 
recommended when conservative treatments 
are ineffective or not tolerated.8
Midurethral mesh tapes were introduced in 
1998 as a novel surgical treatment for female 
SUI.9 A sharp rise in the use of mesh tapes to 
treat SUI followed, due in part to the mini-
mally invasive nature of the procedure, with a 
maximum of 11 365 procedures conducted in 
strengths and limitations of this study
 ► The data used for the study include all surgical pro-
cedures performed within English National Health 
Service (NHS) Hospitals, reducing the risk of selec-
tion bias.
 ► Statistical modelling, using multilevel empirical 
Bayes methods was used to minimise potential es-
timation error problems when identifying potential 
outlier areas.
 ► Unmeasured confounding factors and differences in 
coding practices may have contributed to variation 
in surgery rates.
 ► This study did not account for surgical procedures 
performed in private hospitals. However, it is likely 
that at least 90% of all continence procedures in 
England are provided by the NHS, as the total annual 
spend on private healthcare in England is approx-
imately 5% of the total annual spend on the NHS.
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2009. Over the same period, the previous standard treat-
ment for female SUI, colposuspension (a major abdom-
inal surgery) declined from more than 3500 procedures 
per year to just 200.10 However, after the peak of more 
than 11 000 procedures in 2008–2009, the number of 
mesh procedures for SUI has almost halved, falling to 
just 6227 by 2016-2017.11 12 The decline in the use of 
mesh tapes for SUI has most likely been in response to 
concerns about the safety of mesh13–15 with some women 
experiencing pain, dyspareunia, persistent UI and expo-
sure or erosion.16 17 In 2018, the use of mesh tapes to treat 
SUI was suspended in the National Health Service (NHS) 
in England, following an interim recommendation of 
the Independent Medicines and Medical Devices Safety 
Review.18 19
Previous studies highlighted that not all women with 
SUI have equitable access to appropriate incontinence 
care; access to continence surgery varies by age20 21 and 
ethnic and socioeconomic backgrounds22; with evidence 
of variations in care for other vulnerable populations. In 
light of the current suspension of the use of midurethral 
mesh tapes, the most commonly used procedures to treat 
female SUI, evidence is needed regarding the use of mesh, 
and non-mesh, surgical continence procedures before 
the suspension was in place. A better understanding of 
geographical differences in access to surgical treatment 
for SUI in the English NHS between 2013 and 2016 and 
of the factors contributing to this variation will be infor-
mative for future policy decisions about the appropriate-
ness of surgical treatment of female SUI.
MethODs
study design, setting and definitions
This study used data from Hospital Episode Statistics 
(HES), a routinely collected, administrative dataset 
which contains records of all NHS hospital admissions 
in England. The cohort comprised women aged 20 years 
and older who had received surgical treatment for SUI 
between 1 April 2013 and 31 March 2016 and had an 
SUI diagnosis recorded at the time of the procedure. 
SUI surgery was defined using UK Office for Population 
Censuses and Surveys Classification4 codes (table 1).23 
SUI diagnosis was defined using the International Clas-
sification of Diseases Tenth Revision code: N39.3 SUI.24 
Women may have had repeat procedures in the study 
period, however, only the first operation was counted in 
calculating the rate of surgery.
Measures
The outcome measure was rate of surgery for SUI per 
100 000 women/year at two geographic levels: 209 Clin-
ical Commissioning Group (CCG) and 44 Sustainability 
and Transformation Partnership (STP) areas. CCGs are 
statutory NHS bodies responsible for the planning and 
commissioning of healthcare services in a local area 
(average population size of about 104 000 adult women). 
CCG areas are grouped into 44 STP areas (average 
population size of about 493 000 adult women), which 
were set up to coordinate improvements in the delivery 
of NHS services.25 Reference denominator populations 
were derived by aggregating the 2011 Census popula-
tion counts for women aged 20 and older in lower super 
output areas (LSOA) that are within the respective 
boundaries of the CCG and STP areas. LSOAs are post-
code-based hierarchical geographic units designed to 
improve the reporting of small area statistics in England 
and Wales. There are 32 844 LSOAs in England with an 
average population approximately 1700 people.26
Sociodemographic factors may explain variations in 
rates of surgery for SUI. We handled age as a patient-
level characteristic grouped into five categories (20–39, 
40–49, 50–59, 60–69 and 70+ years). Reference group 
was chosen as 40–49 years of age as surgery for SUI is 
most prevalent for this age group. Socioeconomic status, 
ethnicity and limiting long-term illness were CCG-level 
characteristics derived from 2011 Census data. For socio-
economic status, we used the averages of the national 
ranking of the Index of Multiple Deprivation27 of LSOAs 
within each CCG and grouped the CCG averages into 
national quintiles ranging from 1 (most deprived CCGs) 
to 5 (least deprived CCGs). For ethnicity, we used the 
percentage of the population reporting black or ethnic 
minority (BME) background, and for long-term illness 
the percentage who reported that their day-to-day activi-
ties were limited because of a health problem or disability 
which has lasted, or is expected to last, at least 12 months. 
For each CCG, we took the averages of these percentages 
for LSOAs and grouped these CCG averages into national 
quintiles ranging from 1 (CCGs with average percentages 
in the lowest quintile) to 5 (highest quintile).
statistical analyses
We calculated the number and the unadjusted and 
adjusted rates per 100 000 women/year of SUI proce-
dures overall and according to patient and regional 
characteristics. Incidence rate ratios (IRR) were used to 
represent associations between the procedure rate and 
regional characteristics. Multilevel Poisson regression 
models were used to produce empirical Bayes estimates 
of the unadjusted and adjusted incidence ratesfor each 
CCG and STP area. In addition, risk adjusted regression 
models were used to assess geographic variation in rates of 
surgery by year. The empirical Bayes estimator produces 
more precise results by ‘pulling’ the estimates for small 
outlier regions towards the overall mean.28 For each area 
level (CCG/STP), we illustrated the amount of variation 
in adjusted surgery rates using maps and range plots with 
99.8% credibility intervals. CCGs and STPs were marked 
as ‘outliers’ where the national average rate of surgery was 
not within the 99.8% credibility interval of their rates. All 
statistical calculations were performed using Stata V.14.
Patient involvement
This study was supported by a steering group which 
included lay members and patient representatives who 
Protected by copyright.
 o
n
 Septem
ber 3, 2019 at Royal College of Surgeons of England.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-029878 on 28 August 2019. Downloaded from 
3Mamza JB, et al. BMJ Open 2019;9:e029878. doi:10.1136/bmjopen-2019-029878
Open access
Table 1 OPCS-4 codes and counts of SUI procedures with relevant diagnosis (ICD-10) code N39.3
OPSC-4 Description
All operations* 
N (%)
First operations†
N (%)
Midurethral tape insertions
M53.3 Introduction of tension-free vaginal tape 16 665 (57.9) 16 415 (58.6)
M53.6 Introduction of transobturator tape 8866 (30.8) 8722 (31.2)
Injection of urethral bulking agents
M56.3 Endoscopic injection of inert substance into outlet of female bladder 1628 (5.7) 1435 (5.1)
Other abdominal/vaginal operations
M51.1 Abdominoperineal suspension of urethra 32 (0.1) 29 (0.1)
M51.2 Endoscopic suspension of neck of bladder 6 (<0.1) 6 (<0.1)
M51.8 Other specified combined abdominal and vaginal operations to 
support outlet of female bladder
15 (0.1) 13 (<0.1)
M51.9 Unspecified combined abdominal and vaginal operations to support 
outlet of female bladder
2 (<0.1) 2 (<0.1)
M52.1 Suprapubic sling operation 355 (1.2) 328 (1.2)
M52.2 Retropubic suspension of neck of bladder 78 (0.3) 76 (0.3)
M52.3 Colposuspension of neck of bladder 587 (2.0) 533 (1.9)
M52.8 Other specified abdominal operations to support outlet of female 
bladder
20 (0.1) 15 (0.1)
M52.9 Unspecified abdominal operations to support outlet of female 
bladder
3 (<0.1) 2 (<0.1)
M53.1 Vaginal buttressing of urethra 130 (0.5) 126 (0.5)
M53.8 Other specified vaginal operations to support outlet of female bladder 302 (1.0) 216 (0.8)
M53.9 Unspecified vaginal operations to support outlet of female bladder 5 (<0.1) 4 (<0.1)
M55.2 Implantation of artificial urinary sphincter into outlet of female bladder 18 (0.1) 11 (<0.1)
M55.6 Insertion of retropubic device for female stress urinary incontinence 
NEC
56 (0.2) 52 (0.2)
M55.8 Other specified other open operations on outlet of female bladder 14 (<0.1) 8 (<0.1)
M55.9 Unspecified other open operations on outlet of female bladder 0 (0) 0 (0)
M58.8 Other specified other operations on outlet of female bladder 7 (<0.1) 4 (<0.1)
M58.9 Unspecified other operations on outlet of female bladder 0 (0) 0 (0)
  Total 28 789 27 997
*For 77 episodes of care out of 28 712 eligible episodes, two procedures were recorded and both are included in the overall count.
†For episodes of care where two procedures were recorded, only the more invasive or specified procedure is counted as first operation.
ICD-10, International Classification of Diseases Tenth Revision; N39.3, stress urinary incontinence ICD-10 code; OPCS, Office for Population 
Censuses and Surveys Classification; SUI, stress urinary incontinence.
provided input to the design of the study and interpreta-
tion of the results and contributed to the dissemination 
plan. The steering group met on a regular basis for the 
duration of the study.
results
Description of the cohort
Between April 2013 and March 2016, there were 33 708 
inpatient episodes with a surgical procedure for SUI. Of 
these episodes, 4996 did not satisfy the inclusion criteria, 
for example, because they did not have an SUI diag-
nosis recorded at the time of the procedure, outlined in 
figure 1, and 75 recorded a subsequent operation in the 
study period (figure 1). Of the procedures, 27 997 were 
included in the analyses, 90% of which were midurethral 
mesh tape insertions (table 1). Restricting our analyses 
to these 27 997 first SUI procedures captured >97% of 
all 28 789 SUI procedures in the study period, and the 
distribution of procedure types did not vary between all 
and first procedures (table 1). The national annual rate 
of surgery was 40 procedures per 100 000 women.
Geographic variations in surgery
Figures 2A and 3A show the variation in the unad-
justed empirical Bayes estimates of the procedure rates 
for SUI across the CCGs and STPs, with figures 2B and 
3B illustrating the rates adjusted for patients’ age and 
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Figure 1 Study cohort selection process.This figure is a flow 
diagram of the inclusion process for women who received 
surgical treatment for SUI in England. Data extracted from 
Hospital Episode Statistics 2013–2016. ICD-10, International 
Classification of Diseases, Tenth Revision; N39.3, stress 
urinary incontinence ICD-10 code; SUI, stress urinary 
incontinence.
Figure 2 CCG-level rates of stress urinary incontinence procedures between 2013 and 2016. The figure shows the EB 
estimated procedure rates for stress urinary incontinence. The vertical axes in (A) and (B) are EB rates. Rates in (B) are risk-
adjusted for age, socioeconomic status, ethnicity and long-term illness. The numbers on the horizontal axis represent the 
assigned position of the CCG ranked according to rates. Geographical mapping in (C) highlight the locations of CCGs with the 
lowest to highest range of procedure rates in England as well as an expanded section of the London Commissioning Region. 
CCGs were not labelled because of space constraints. CCG, Clinical Commissioning Group; EB, empircal Bayes.
the CCG-level characteristics: socioeconomic status, 
percentage of the population reporting BME background, 
and percentage with a long-term illness. Figures 2C and 
3C highlight the locations of CCGs/STPs with the lowest 
to highest range of procedure rates in England.
The adjusted SUI procedure rates for CCGs ranged 
from 20 to 106 procedures compared with unadjusted 
rates of 11 to 120 procedures per 100 000 women/year 
(figure 2). Ninety-nine CCGs (47%) were marked as 
‘outliers’ (where the national average was not within the 
99.8% credibility interval of their rate). These comprised 
43 CCGs (20.6%) with rates below the national average 
and 56 CCGs (26.8%) with rates above the national 
average. Risk adjustment reduced the number of CCGs 
marked as ‘outliers’ from 99 (47.4%) to 75 (36%). The 
SD of the CCG-level variation in adjusted rates (SD 0.27, 
95% CI 0.24 to 0.30) was 16% lower than the SD of the 
unadjusted rates (SD 0.32, 95% CI 0.29 to 0.36).
The adjusted SUI procedure rates for STPs ranged 
from 24 to 69 procedures compared with unadjusted 
rates of 20 to 77 per 100 000 women/year (figure 3). Risk 
adjustment reduced the number of STPs identified as 
outliers from 23 (52%) to 22 (50%). The amount of vari-
ation observed declined by 35% after risk adjustment: the 
SD of the STP-level variation for unadjusted and adjusted 
model were 0.23 (95% CI 0.17 to 0.31) and 0.15 (95% CI 
0.11 to 0.22), respectively.
Annual SUI procedure rates declined over the study 
period from 52 per 100 000 women in 2013 to 36 per 
100 000 women in 2015. However, there was no evidence Protected by copyright.
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Figure 3 STP-level rates of stress urinary incontinence procedures between 2013 and 2016. The figure shows the EB 
estimated procedure rates for stress urinary incontinence. The vertical axes in (A) and (B) are EB rates. Rates in (B) are risk-
adjusted for age, socioeconomic status, ethnicity and long-term illness. The numbers on the horizontal axis represent the 
assigned position of the STP footprint ranked according to rates. Geographical mapping in (C) highlight the locations of STP 
footprints with the lowest to highest range of procedure rates. EB, empirical Bayes; STP, Sustainability and Transformation 
Partnership.
that CCG- or STP-level variation changed over time. 
In separate (adjusted) regression models run by year, 
the SD of CCG-level variation was 0.26 (95% CI 0.23 to 
0.30) in 2013; 0.27 (95% CI 0.23 to 0.31) in 2014 and 
0.29 (95% CI 0.25 to 0.34) in 2015. The SD of STP-level 
variation (adjusted model) was 0.13 (95% CI 0.08 to 
0.20) in 2013, 0.17 (95% CI 0.11 to 0.25) in 2014 and 
0.18 (95% CI 0.12 to 0.26) in 2015.
Association of patient and regional characteristics with 
surgery rates
Table 2 shows the rates of surgery by regional character-
istics. Rates were lowest for the 20–39 year age group (16 
per 100 000 women/year), and highest for 40–49 year age 
group (84 per 100 000 women/year), declining with age 
beyond 50 years. Compared with the rate among women 
aged 40–49 years, the surgery rate for women aged 50–59 
years was 20% lower (IRR 0.80, 95% CI 0.78 to 0.83), for 
women aged 60 to 69 years was 46% lower (IRR 0.54, 
95% CI 0.52 to 0.56), and for women aged 70+years was 
69% lower (IRR 0.31, 95% CI 0.30 to 0.33).
Rates of surgery were lower for areas with higher propor-
tions of BME populations (highest vs lowest quintile IRR 
0.63, 95% CI 0.49 to 0.81). There were no differences in 
surgery rates according to the proportion of people with 
long-term limiting illness or socioeconomic deprivation 
at the CCG level.
DIsCussIOn
Main findings
More than 30 000 women were admitted to NHS hospitals 
in England for an SUI-related surgical treatment between 
April 2013 and March 2016. The rate of surgery for 
SUI was 40 procedures per 100 000 women/year. Crude 
regional rates varied by a factor of 11 among the 209 
CCGs from 11 to 120, and a factor of 4 among 44 STPs 
from 20 to 77 procedures per 100 000 women/year. These 
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Table 2 Regional characteristics and their association with SUI procedure rates
Regional factor
Scale of factor 
(one unit) Procedures, n (%)
Crude rate per 
100 000 women/year
Procedure rate ratio 
(95% CI) P value*
Age categories (years)
  20–39 Age group in 
years
3253 (11.6) 15.9 0.18 (0.17 to 0.19)
  40–49 9761 (34.9) 84.4 Reference <0.001
  50–59 7496 (26.8) 67.5 0.80 (0.78 to 0.83)
  60–69 4352 (15.5) 46.2 0.54 (0.52 to 0.56)
  ≥70 3135 (11.2) 26.8 0.31 (0.30 to 0.33)
Socioeconomic status
  Most deprived Quintile category 
of
5838 (20.9) 43.0 Reference 0.84
  More deprived IMD ranking 6315 (22.6) 47.5 1.08 (0.93 to 1.25)
  Average 6371 (22.8) 47.9 1.05 (0.89 to 1.25)
  Less deprived 5001 (17.9) 39.9 1.02 (0.85 to 1.21)
  Least deprived 4472 (15.1) 36.3 1.05 (0.85 to 1.29)
Black and minority ethnic population
  1: CCGs with lowest 
proportion
Ranked category 
of
5579 (19.9) 48.8 Reference 0.001
  2 Proportion of 
BME
6867 (24.5) 49.8 1.02 (0.89 to 1.17)
  3 Population 6326 (22.6) 45.7 1.00 (0.86 to 1.17)
  4 5725 (20.4) 41.5 0.89 (0.75 to 1.06)
  5: CCGs with highest 
proportion
3500 (12.5) 27.2 0.63 (0.49 to 0.81)
Limiting long-term illness
  1: CCGs with lowest 
proportion
Ranked category 
of
4433 (15.8) 32.8 Reference 0.46
  2 Proportion of 
people with
6328 (22.6) 44.4 1.16 (0.99 to 1.36)
  3 Limiting illness 4882 (17.4) 43.7 1.11 (0.91 to 1.34)
  4 6896 (24.6) 46.1 1.12 (0.91 to 1.39)
  5: CCGs with highest 
proportion
5458 (19.5) 48.9 1.16 (0.91 to 1.49)
Random effects estimates SD† (95% CI) SD‡ (95% CI)
  STP-level variation 
(level 2)
0.23 (0.17–0.31) 0.15 (0.11 to 0.22)
  CCG-level variation 
(level 1)
0.32 (0.29–0.36) 0.27 (0.24 to 0.30)
This table describes the distribution of regional characteristics and the association between these factors and SUI procedure rates from the 
multilevel random-intercept Poisson regression model.
*P value obtained from likelihood ratio test.
†Unadjustedestimates.
‡Adjusted for all regional factors including ethnicity.
CCG, Clinical Commissioning Group; IMD, Index of multiple deprivation; STP, Sustainability and Transformation Plan; SUI, stress urinary 
incontinence.
differences were only slightly reduced when the women’s 
age and regional characteristics were taken into account. 
The overall rate of SUI surgery dropped by a third over 
the 3-year study period, while the extent of geographic 
variation remained stable.
Interpretation
This study, carried out in the English NHS, is the first 
national study to explore geographic variation in rates of 
surgical treatment for SUI. Evidence to date regarding 
geographic variation in benign gynaecological surgery 
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across England focused primarily on surgery for menor-
rhagia29 30 suggesting substantial variation despite the 
existence of national guidelines.
We found that women’s age and regional ethnicity 
distributions were associated with surgery rates. This 
may reflect differences in incontinence-related health 
beliefs, preferences and care seeking behaviour for older 
women31 and women from various ethnic backgrounds22 
or inequitable use of surgical care.32 Studies suggest that 
only around half of older people seek help for their 
incontinence symptoms, commonly due to the belief 
that it is a normal part of ageing.33 34 In England, studies 
concluded that help-seeking behaviour was hindered for 
South-Asian women as they felt embarrassed to discuss 
sensitive problems, particularly with a male health profes-
sional.35 36 Other studies in the Netherlands,37 Sweden38 
and the USA39 also found notable differences in prefer-
ences across women from different age groups and ethnic 
backgrounds.
We found that older women were less likely to have 
received surgical treatment for their SUI. This agrees 
with findings for other aspects of continence care. A 
national audit for continence care in the UK20 found that 
deficiencies in the organisation of care and the manage-
ment of UI were more pronounced for older people.40 
For example, in acute and primary care settings, older 
people were less likely to have a continence history or 
focused examination done. In secondary care, while it has 
been shown that surgical treatments are safe and effec-
tive in older women,41 these procedures were used less 
frequently than in younger patients.20 42
In their work on clinical practice variation, Wenn-
berg and colleagues emphasise three factors as possible 
sources of variation: clinical uncertainty about the appro-
priateness of care, regional differences in patients’ pref-
erences for particular treatments and differences in the 
capacity or supply of services.43 In the context of SUI 
surgery, a part of the observed variation will reflect the 
ongoing debate and concerns about the safety of midure-
thral mesh tape procedures for women with SUI, which in 
2018 led to a ‘pause’ in the use of mesh for the treatment 
of stress urinary incontinence.13–15 18 19 It is important to 
note that adjustment for factors that are likely to affect 
patients’ preferences had little impact on the geographic 
variation we observed for SUI surgery. However, patients’ 
preferences will also be strongly guided by the advice 
received from their clinicians. The geographic areas used 
in this study (CCGs and STPs) are defined by NHS bodies 
that commission local hospital services which suggests 
that differences in capacity of the local healthcare system 
may have contributed to the observed variation.
The ‘correct’ rate of SUI surgery is difficult to deter-
mine, especially given the ongoing concerns about the 
safety of mesh tapes. However, with the observed level 
of geographic variation, it is likely that women in some 
areas were more likely to be treated compared with 
women with the same condition in other areas. Informed 
patient choice, shared decision-making and improved 
communication of the risks and benefits of both mesh 
and non-mesh procedures44 is often proposed as a 
possible solution.43 The National Institute for Health and 
Care Excellence (NICE), the organisation that develops 
clinical guidelines for the English NHS, recommends a 
multidisciplinary team review prior to offering invasive 
therapy for SUI symptoms.8 In light of recent reviews and 
the current suspension of mesh tape insertions, NICE’s 
latest draft guidance (published October 2018) also states 
that non-surgical options for SUI must be offered before 
any surgical treatment.45 A better understanding of rele-
vant, long-term clinical outcomes is also needed.46 47 
With the current level of uncertainty about the safety and 
outcomes of midurethral mesh tape insertions, it is likely 
that the geographic variation we observed will continue.
In England, discussions are ongoing about setting 
up a national prospective registry of midurethral mesh 
tape insertions to monitor reoperations and removals as 
outcomes. However, there is also a clear need to capture 
a wider range of clinical outcomes that are directly rele-
vant to women, including recurrent or persistent urinary 
incontinence, pain and sexual dysfunction. These types 
of outcomes can only be collected if women themselves 
are actively involved in the process.
strengths and limitations of this study
The data used comprised information on all surgical 
procedures performed within the English NHS, thereby 
reducing the risk of selection bias. Our statistical model-
ling, using multilevel empirical Bayes methods allowed 
for minimising potential estimation error problems and 
taking account of area size variations for estimation of 
credibility intervals.28 This approach provided a powerful 
and statistically robust basis for identifying potential 
outlier areas.
Our analyses were subject to limitations inherent to 
observational studies. First, unmeasured confounding 
factors may have contributed to variation in surgery rates. 
We were unable to account for potential regional varia-
tion in the average severity of the SUI problems. Second, 
while the overall quality of clinical information in HES has 
been found to be sufficiently high for research and audit 
purposes, inaccuracies in coding practices could have intro-
duced some variation between geographic areas. Finally, we 
were unable to account for procedures done in the private 
sector. Although precise figures are lacking, it is likely that 
at least 90% of all incontinence procedures carried out 
in England are provided by the NHS, given that the total 
annual spending on private healthcare in England is about 
5% of the total annual spending on the NHS.48 While our 
study findings must be interpreted with caution in light of 
the above limitations, these are very unlikely to explain the 
large regional differences observed.
COnClusIOn
We found substantial variation in the rates of surgical 
treatment for female SUI between geographic regions 
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across England. Adjusting for the women’s age group 
and regional characteristics reduced variation only 
slightly. It is likely that the observed variation is in part 
linked to the ongoing debate about the safety of midure-
thral mesh tapes leading to differences in professional 
opinion about the appropriateness of surgical treatment 
for female SUI. This can only be informed by large-scale 
national studies monitoring long-term outcomes rele-
vant to patients.
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